Kimberly-Clark Corp

Most Recent

  • uploads///CLX SALES
    Consumer

    Analyzing Clorox’s Performance in the Fourth Fiscal Quarter

    Clorox (CLX) reported net sales of $1.7 billion, which fell short of analysts’ expectation. However, the net sales increased 2.7% YoY.

    By Amit Singh
  • uploads///detergent _
    Consumer

    Procter & Gamble Beats Third-Quarter Estimates

    Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23.

    By Amit Singh
  • uploads///Cl Developed
    Earnings Report

    Colgate-Palmolive’s Developed Markets Remained a Drag in 1Q17

    Net sales in North America fell 5.0% in 1Q17, reflecting a strong decline in volumes coupled with lower pricing.

    By Amit Singh
  • uploads///KMB EPS
    Consumer

    Factors That Could Impact Kimberly-Clark’s Earnings in 2018

    Kimberly-Clark (KMB) has managed to increase its EPS (earnings per share) despite volume deleveraging.

    By Amit Singh
  • uploads///KMB Margins
    Consumer

    Why Kimberly-Clark Stock Is Down 12.5% Year-to-Date

    Similar to its peers, Kimberly-Clark stock is also trading in the red and is down about 12.5% on a YTD (year-to-date) basis as of March 26, 2018.

    By Amit Singh
  • uploads///CL Sales
    Consumer

    Will Colgate-Palmolive Sustain Sales Momentum in 1Q18?

    Analysts expect Colgate-Palmolive (CL) to report sales of $4.0 billion in 1Q18, which represents a YoY (year-over-year) rise of 6.6%.

    By Amit Singh
  • uploads///US
    Macroeconomic Analysis

    Government Sector Influenced Personal Income and Expenses Rose

    According to the BEA, personal income rose 0.30% to $52.5 billion in August 2015. This was below the consensus estimate of 0.40%.

    By Lara Sheldon
  • uploads///KMB Sales
    Consumer

    Kimberly-Clark Stock: Headwinds Could Stall the Uptrend

    Analysts expect Kimberly-Clark’s sales and margins to remain weak in the near term. Kimberly-Clark’s top line is projected to decline.

    By Amit Singh
  • uploads///FQ preview sales
    Earnings Report

    Clorox’s Fiscal 2Q16 Revenue Is Estimated to Be $1.3 Billion

    For fiscal 2Q16, Wall Street analysts’ consensus revenue estimate for Clorox is ~$1.3 billion, a 3.4% rise from the same quarter last year.

    By Penny Morgan
  • uploads///Cl Margins
    Earnings Report

    What Drove Colgate-Palmolive’s Margins Growth in 1Q17?

    Colgate-Palmolive (CL) witnessed improved margins in 1Q17 despite soft sales thanks to its “Funding the Growth” initiative aimed at reducing costs and driving efficiency.

    By Amit Singh
  • uploads///PG Segment
    Consumer

    How Procter & Gamble’s Segments Performed in 3Q18

    Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity.

    By Amit Singh
  • uploads///CLX EPS
    Consumer

    Why Analysts Expect Clorox’s Earnings to Fall in Fiscal 2Q18

    Analysts expect Clorox to report adjusted earnings of $1.23 per share, a YoY (year-over-year) decline of 1.6%.

    By Amit Singh
  • uploads///CL ANR
    Consumer

    Why SunTrust Upgraded Colgate-Palmolive Stock

    On October 11, 2017, SunTrust Robinson Humphrey upgraded Colgate-Palmolive (CL) stock to a “buy” from “hold” and increased the target price.

    By Amit Singh
  • uploads///pg pic
    Miscellaneous

    Will Procter & Gamble’s Sales Improve in Fiscal 2017?

    After generating lower sales for 11 consecutive quarters, Procter & Gamble (PG) managed to report flat sales growth in fiscal 1Q17.

    By Gabriel Kane
  • uploads///CLX Rating
    Consumer

    Analysts Remain Neutral on Clorox Stock before 4Q17 Results

    Analysts covering Clorox (CLX) have rated the stock a 2.9 on a scale of one (strong buy) to five (strong sell) and maintain a neutral outlook.

    By Amit Singh
  • uploads///KMB EPS
    Consumer

    Will Cost Pressures Hurt KMB’s Q2 2018 EPS Growth Rate?

    Analysts expect Kimberly-Clark (KMB) to report adjusted EPS of $1.57 in the second quarter.

    By Amit Singh
  • uploads///PG Margins
    Company & Industry Overviews

    Procter & Gamble’s Margins Could Remain Muted

    Procter & Gamble’s management remains upbeat and expects productivity savings to drive its margins higher in coming quarters.

    By Amit Singh
  • uploads///CLX EPS
    Earnings Report

    What’s behind Clorox’s Fiscal 3Q17 Earnings Beat?

    The Clorox Company (CLX) reported its fiscal 3Q17 results on May 3, 2017. Its EPS (earnings per share) of $1.31 exceeded analysts’ consensus estimate of $1.30.

    By Amit Singh
  • uploads///clx anr
    Earnings Report

    How Do Analysts Rate Clorox and Its Peers?

    Of the 17 analysts covering Clorox Company (CLX), two analysts have rated the stock as a “buy” as of November 2.

    By Gabriel Kane
  • uploads///PG valuation
    Earnings Report

    How PG’s Valuation Compares to Peers

    As of April 18, Procter & Gamble (PG) was trading at a 12-month forward PE (price-to-earnings) ratio of 22.8x.

    By Amit Singh
  • uploads///pg pm
    Company & Industry Overviews

    Henkel Acquired Procter & Gamble’s Haircare Brands

    Procter & Gamble (PG) has a market cap of $224.1 billion. PG rose by 0.35% to close at $82.84 per share on March 3, 2016.

    By Gabriel Kane
  • uploads///Valuation_PG
    Miscellaneous

    How PG’s Valuation Looks Now

    As of March 8, PG was trading at a 12-month forward PE ratio of 22.7x. The company is now trading at a higher valuation multiple than the S&P 500 Index.

    By Amit Singh
  • uploads///kmb pm
    Company & Industry Overviews

    Kimberly-Clark Appoints Scott Usitalo as Chief Marketing Officer

    Kimberly-Clark (KMB) has a market cap of $47.6 billion. It rose by 1.7% to close at $132.41 per share on June 14, 2016.

    By Gabriel Kane
  • uploads///Q Pre Sales earnings
    Earnings Report

    Procter & Gamble: Can Focus on 10 Product Categories Help 3Q16?

    Procter & Gamble (PG) is set to release its fiscal 3Q16 earnings before the Markets open on April 26, 2016. In fiscal 2Q16, P&G missed revenue estimates for the fifth consecutive quarter.

    By Penny Morgan
  • uploads///Inventory
    Company & Industry Overviews

    How Is Clorox Improving Product Distribution?

    For distribution in the United States, Clorox (CLX) sells or markets its products primarily through mass retail outlets, e-commerce channels, wholesale distributors, and medical supply distributors.

    By Penny Morgan
  • uploads///Growth
    Macroeconomic Analysis

    Mega Brands Set to Dominate in P&G’s New Product Portfolio

    P&G plans to focus on superior brands in the 10 product categories in its portfolio. It expects one-third of them to surpass $1 billion in annual sales.

    By Penny Morgan
  • uploads///clx pm
    Company & Industry Overviews

    Why Did Clorox China Recall Some of Its Products?

    The Clorox Company (CLX) has a market cap of $15.0 billion. It fell 0.67% and closed at $115.48 per share on November 23, 2016.

    By Gabriel Kane
  • uploads///kleenex _
    Consumer

    Will Sales and Cost Headwinds Stall the Recovery in KMB Stock?

    Shares of Kimberly-Clark (KMB) have increased 8.5% since the company reported better-than-expected third-quarter results on October 22.

    By Amit Singh
  • uploads///PG EPS
    Earnings Report

    Here’s What’s behind PG’s Fiscal 3Q17 Bottom Line Beat

    Procter & Gamble reported its fiscal 3Q17 results on April 26, 2017. Its adjusted EPS of $0.96 exceeded Wall Street’s consensus estimate of $0.94 and jumped 11.6% YoY (year-over-year), thanks to lower taxes.

    By Amit Singh
  • uploads///cl pe
    Earnings Report

    How Does Colgate-Palmolive’s Valuation Compare?

    12-month forward price-to-earnings multiple As of January 17, Colgate-Palmolive (CL) was trading at a 12-month forward PE (price-to-earnings) multiple of 22.2x. The company is currently trading at a higher valuation multiple than the S&P 500, which has a forward PE of 17.6x, and the S&P 500 Consumer Staples, which has a forward PE of 20.3x. […]

    By Gabriel Kane
  • uploads///pg pm
    Company & Industry Overviews

    Procter & Gamble Kicked off the Campaign for Its Pantene Brand

    Procter & Gamble (PG) fell 1.8% to close at $83.58 per share during the second week of November 2016.

    By Gabriel Kane
  • uploads///Q Margins
    Macroeconomic Analysis

    Weak Currencies, but Consumer Packaged Goods Margins Improved

    The 1Q16 margins of consumer packaged goods (or CPG) companies sent strong signals. These companies have been investing heavily in innovative products and other growth initiatives.

    By Penny Morgan
  • uploads///toilet paper _
    Consumer

    What Could Stall the Recovery in Kimberly-Clark Stock?

    Kimberly-Clark (KMB) stock has recovered nearly 6% in the last two trading days.

    By Amit Singh
  • uploads///CL Sales
    Consumer

    What Dragged Colgate-Palmolive’s Sales Down in Q4?

    Colgate-Palmolive (CL) posted net sales of $3.8 billion, a decline of about 2% on a YoY (year-over-year) basis, as unfavorable currency rates hurt the top line by 5%.

    By Amit Singh
  • uploads///ST UDE
    Fund Managers

    Millennium Management adds new position in St. Jude Medical

    St. Jude Medical, Inc. is a global medical device company founded in 1976. It has more than 20 principal operations and manufacturing facilities worldwide.

    By Adam Rogers
  • uploads///sharon mccutcheon  unsplash
    Company & Industry Overviews

    What’s behind Procter & Gamble’s Improving Dividend Trend?

    Procter & Gamble recently announced a 4% hike in its quarterly dividend to $0.72 per share.

    By Amit Singh
  • uploads///clx pm
    Company & Industry Overviews

    Barclays Upgraded Clorox to ‘Equal-Weight’

    On January 9, 2017, Barclays upgraded Clorox’s rating to “equal-weight” from “underweight.” It set the stock’s price target at $111.0 from $115.0 per share.

    By Gabriel Kane
  • uploads///Stock price
    Earnings Report

    Can Procter & Gamble’s Stock Price Gain Momentum?

    Procter & Gamble’s stock has consistently fallen since the beginning of 2015. However, the stock was able to sustain some gains until September.

    By Penny Morgan
  • uploads///Cl margins
    Earnings Report

    Why Colgate-Palmolive’s Margins May Improve in 2Q17

    Colgate-Palmolive (CL) has resorted to cost-cutting and productivity savings measures to drive margins growth.

    By Amit Singh
  • uploads///CLX Sales
    Consumer

    Why Clorox’s Top Line Could Continue to Impress in 2018

    Clorox (CLX) registered healthy volumes growth in the United States (SPY) in 2017, which differentiates it from its peers.

    By Amit Singh
  • uploads///KMB Margins
    Consumer

    Why Kimberly-Clark’s Gross Margins Fell Significantly in 1Q18

    Kimberly-Clark’s adjusted operating margin fell 140 basis points to 17.4%, reflecting a lower gross margin.

    By Amit Singh
  • uploads///CLX Sales
    Consumer

    Clorox Disappoints on Outlook

    Clorox (CLX) continued its strong top-line and bottom-line performances in fiscal 1Q18.

    By Amit Singh
  • uploads///KMB EPS
    Consumer

    Why Kimberly-Clark’s EPS Could Decline in Q1 2019

    Analysts expect Kimberly-Clark to post adjusted earnings of $1.54 per share in the first quarter of 2019, which implies a YoY decline of 9.9%.

    By Amit Singh
  • uploads///KMB Sales
    Consumer

    Could Kimberly-Clark’s Sales Recover in 2018?

    Continued challenges in developed markets, especially North America, have taken a toll on Kimberly-Clark’s (KMB) top-line performance.

    By Amit Singh
  • uploads///KMB ANR
    Consumer

    What Could Hurt Kimberly-Clark Stock?

    Among 19 analysts covering Kimberly-Clark stock, 13 recommend a “hold,” four recommend a “sell,” and two recommend a “buy” rating.

    By Amit Singh
  • uploads///CL cost drivers
    Company & Industry Overviews

    How Colgate Is Maintaining Margins in the Face of Headwinds

    Colgate’s worldwide gross profit margin fell to 58.5% in 2014 from 58.6% in 2013.

    By Penny Morgan
  • uploads///CLX_volume
    Consumer

    What’s Behind Clorox’s Industry-Leading Sales Growth?

    The Clorox Company (CLX) has managed to generate industry-leading sales despite challenges.

    By Amit Singh
  • uploads///PG ANR
    Consumer

    Procter & Gamble Stock: Analysts’ Ratings Trend

    Of the 23 analysts covering Procter & Gamble stock, 74.0% recommend a “hold,” 22.0% recommend a “buy,” and 4.0% recommend a “sell.”

    By Amit Singh
  • uploads///KMb Margins
    Earnings Report

    Here’s What Drove Kimberly-Clark’s Margins in 1Q17

    Kimberly-Clark (KMB) generated about $110.0 million in cost savings in 1Q17 and remains on track to save about $400.0 million in 2017.

    By Amit Singh
  • uploads///Clorox
    Consumer

    Will the Rally in Clorox Stock Continue?

    The COVID-19 pandemic boosted Clorox’s (NYSE:CLX) sales. People started paying more attention to cleaning and sanitizing.

    By Sirisha Bhogaraju
  • uploads///Clorox Q Post
    Consumer

    Is Clorox a ‘Buy’ after Its Stellar Q3 Results?

    Clorox (NYSE:CLX) raised its outlook for 2020 after the company generated strong sales in the third quarter of fiscal 2020.

    By Sirisha Bhogaraju
  • uploads///Clorox
    Consumer

    Why Investors Expect Clorox to Deliver Strong Q1 Results

    Increased hygiene requirements amid COVID-19 caused a major rise in demand for Clorox’s tissues, disinfectants, and other cleaning products.

    By Sirisha Bhogaraju
  • uploads///procter and gamble earnings
    Consumer

    Procter & Gamble Delivers Mixed Q3 Results amid COVID-19

    Today, Procter & Gamble (NYSE:PG) announced better-than-expected earnings for the third quarter of fiscal 2020. The fiscal third quarter ended on March 31.

    By Sirisha Bhogaraju
  • uploads///Procter Gamble Stock
    Consumer

    Jefferies Upgraded Procter & Gamble and Kimberly Clark

    Jefferies is bullish about consumer staples giants Procter & Gamble (NYSE:PG) and Kimberly Clark (NYSE:KMB). The firm upgraded both of the stocks.

    By Sirisha Bhogaraju
  • uploads///procter and gamble bet
    Consumer

    Is Procter & Gamble a Good Bet for Investors?

    The defensive nature of Procter & Gamble stock and its strong dividends make it a good buy in a challenging market environment.

    By Sirisha Bhogaraju
  • uploads///clorox stock coronavirus
    Consumer

    Clorox Gets Rating Upgrade, Coronavirus Triggers Demand

    Clorox stock rose 4.1% on March 16, even though the US stock market crashed amid the coronavirus pandemic. JPMorgan Chase upgraded its rating.

    By Sirisha Bhogaraju
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Why 2019 Wasn’t As Good As 2018 for Church & Dwight Stock

    Although Church & Dwight stock is trading in the green, it has lagged its peers and the broader markets. The stock didn’t repeat its 2018 performance.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Procter & Gamble Stock: What’s Fueling the Growth?

    Procter & Gamble stock has generated a significant amount of wealth for investors this year. The company boosted shareholders’ returns.

    By Amit Singh
  • uploads///AdobeStock_
    Consumer

    Why Church & Dwight Stock Is Underperforming Its Peers

    Church & Dwight stock is lagging behind its peers by a wide margin so far this year. High valuation and moderating growth are to blame.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Why Colgate-Palmolive’s Q3 Earnings Failed to Impress

    Colgate-Palmolive released its third-quarter earnings results today. The company’s performance was mixed, irking investors.

    By Amit Singh
  • uploads///AdobeStock_
    Consumer

    Why Church & Dwight Fell despite Its Q3 EPS Beat

    Church & Dwight (CHD) stock was trading about 4% lower in morning trading after its third-quarter sales miss irked investors.

    By Amit Singh
  • uploads///AdobeStock_
    Consumer

    Church & Dwight Stock: Q3 Earnings Might Spur Growth

    Most of the analysts maintained a neutral outlook on Church & Dwight stock before the third-quarter earnings announcement.

    By Amit Singh
  • uploads///AdobeStock_
    Consumer

    Why Procter & Gamble Stock Might Not Cool Off

    So far, Procter & Gamble stock has outperformed the broader markets by a wide margin. Procter & Gamble stock has risen 33.8% on a YTD basis.

    By Amit Singh
  • uploads///AdobeStock_
    Consumer

    Procter & Gamble Crushed Estimates, Stock Rose

    Procter & Gamble (PG) posted impressive results for the first quarter of fiscal 2020 today. The company’s revenues and EPS beat analysts’ estimates.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Procter Gamble: Q1 Earnings Could Drive Its Stock

    Procter & Gamble (PG) is scheduled to announce its earnings for the first quarter of fiscal 2020 before the markets open on Tuesday.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Procter & Gamble: Fiscal 2020 Could Start Strong

    Procter & Gamble was up 27.9% YTD on October 16, outperforming the broader markets by a wide margin. PG plans to announce its Q1 earnings on October 22.

    By Amit Singh
  • uploads///PG Organic sales
    Consumer

    P&G Beats Estimates and Posts Best Organic Sales in Decade

    P&G’s sales and EPS handily exceeded analysts’ expectations thanks to the robust organic sales growth.

    By Amit Singh
  • uploads///Kimberly Clark Clorox
    Company & Industry Overviews

    Kimberly-Clark and Clorox: Barclays Is Bullish and Bearish

    On September 23, Barclays analyst Lauren Lieberman upgraded Kimberly-Clark (KMB) stock and downgraded the Clorox Company (CLX) stock.

    By Amit Singh
  • uploads///Procter Gamble
    Consumer

    Procter & Gamble Stock: Valuation Limits Upside

    Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.

    By Amit Singh
  • uploads///Church Dwight
    Consumer

    Church & Dwight Stock: Valuation Overshadows Growth

    Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.

    By Amit Singh
  • uploads///Procter Gamble stock
    Consumer

    Will Procter & Gamble Stock Sustain the Rally?

    While we expect sustained momentum in the base business to support Procter & Gamble stock, its valuation suggests otherwise.

    By Amit Singh
  • uploads///CL KMB
    Consumer

    CL and KMB: Why Their Upside May Be Capped

    CL and KMB stocks have outperformed the broader markets this year. However, any further upside in the stocks seems capped.

    By Amit Singh
  • uploads///Procter Gamble Stock
    Consumer

    Procter & Gamble Stock: What’s behind Its Solid Return?

    Procter & Gamble stock benefits from its strong organic sales. On average, the company’s organic sales have increased by 5% in the last four quarters.

    By Amit Singh
  • uploads///dividend stock
    Consumer

    Why These Dividend-Paying Consumer Stocks Look Attractive

    As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.

    By Amit Singh
  • uploads///Clorox
    Consumer

    Clorox Posts Mixed Q4 Results, Weakness to Persist

    On Thursday, Clorox posted mixed fourth-quarter results. Clorox reported net revenues of $1.63 billion, which fell short of analysts’ estimate.

    By Amit Singh
  • uploads///Colgate CL
    Consumer

    Colgate-Palmolive’s Q2 EPS Met Estimates

    Colgate-Palmolive (CL) announced its second-quarter results on July 26.

    By Amit Singh
  • uploads///Procter Gamble
    Consumer

    Procter & Gamble Will Likely Beat Q4 Estimates

    Procter & Gamble (PG) is scheduled to announce to its fourth-quarter earnings on July 30. We expect the company to beat analysts’ estimates.

    By Amit Singh
  • uploads///Kimberly Clark
    Consumer

    Kimberly-Clark Beats Estimates, Raises Guidance

    On July 23, Kimberly-Clark (KMB) posted stronger-than-expected second-quarter earnings results. It surpassed analysts’ expectations on both the sales and EPS fronts.

    By Amit Singh
  • uploads///KMB
    Consumer

    Will Kimberly-Clark’s Q2 Boost Its Share Price?

    Kimberly-Clark (KMB) will likely report its second-quarter results before the markets open on July 23. We expect the company’s sales and earnings to stay muted.

    By Amit Singh
  • uploads///soap _
    Miscellaneous

    Church & Dwight Continues to Outperform with Its Earnings Growth

    Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five out of the past six quarters.

    By Amit Singh
  • uploads///kleenex _
    Miscellaneous

    Why Kimberly-Clark Stock May Stop Rising

    Kimberly-Clark (KMB) stock has risen 20.5% this year, boosted by the company’s better-than-expected sales and earnings during its last reported quarter. However, its stock could stop climbing. Here’s why.

    By Amit Singh
  • uploads///detergent _
    Consumer

    Why Clorox Stock Is Underperforming Peers

    Clorox stock (CLX) is down about 8% since the company posted its third quarter of fiscal 2019 earnings on May 1.

    By Amit Singh
  • uploads///CHD Stock
    Consumer

    Q1 Beat and Improved Outlook Could Boost Church & Dwight Stock

    Church & Dwight (CHD) has impressed with its better-than-expected first-quarter results and margin expansion.

    By Amit Singh
  • uploads///CLX Sales
    Consumer

    Currency and Competition Hurt Clorox’s Q3 Sales

    Clorox (CLX) posted net sales of $1.55 billion, which fell short of Wall Street’s estimate of $1.57 billion.

    By Amit Singh
  • uploads///clean _
    Consumer

    Clorox Stock Drops 7.2% on Weak Quarterly Results

    Clorox (CLX) stock fell 7.2% on May 1 following the company’s weaker-than-expected third-quarter results.

    By Amit Singh
  • uploads///toothpaste _
    Consumer

    What’s on the Horizon for Colgate-Palmolive Stock?

    Most of the analysts maintained a neutral stance on Colgate-Palmolive stock. Persistent challenges will likely limit the upside.

    By Amit Singh
  • uploads///toothpaste _
    Consumer

    Colgate-Palmolive Beats Estimates on Higher Pricing

    Colgate-Palmolive (CL) posted better-than-expected first-quarter earnings results on April 26.

    By Amit Singh
  • uploads///PG Organic sales
    Consumer

    Procter & Gamble Posted Strong Sales in Q3

    Procter & Gamble (PG) posted better-than-expected third-quarter sales. Procter & Gamble’s net sales of $16.5 billion beat analysts’ estimate.

    By Amit Singh
  • uploads///beauty _
    Consumer

    Procter & Gamble Stock Fell despite Strong Q3 Results

    Procter & Gamble posted impressive third-quarter results on April 23. Organic sales rose 5% due to stellar growth in the United States and China.

    By Amit Singh
  • uploads///KMB EPS
    Consumer

    What Drove Kimberly-Clark’s Q1 Earnings?

    Kimberly-Clark (KMB) posted better-than-expected earnings in the first quarter of 2019.

    By Amit Singh
  • uploads///KMB Sales
    Consumer

    What’s behind Kimberly-Clark’s Strong Organic Sales?

    Kimberly-Clark (KMB) posted better-than-expected first-quarter sales thanks to the strong growth in its base business.

    By Amit Singh
  • uploads///kitchen towel _
    Consumer

    Kimberly-Clark Stock Rose on Stronger-Than-Expected Q1 Results

    Kimberly-Clark (KMB) stock rose 5.4% on April 22 after the company released stronger-than-expected first-quarter results.

    By Amit Singh
  • uploads///toothpaste _
    Consumer

    Persisting Challenges Could Hurt Colgate-Palmolive in Q1

    Colgate-Palmolive (CL) is scheduled to announce its first-quarter earnings results before the market opens on April 26.

    By Amit Singh
  • uploads///PG ANR
    Consumer

    What Analysts Suggest for PG Stock ahead of Its Q3 Results

    The majority of analysts continue to suggest “holds” on Procter & Gamble (PG) stock.

    By Amit Singh
  • uploads///detergent _
    Consumer

    What to Expect from Procter & Gamble’s Q3 2019 Results

    Procter & Gamble (PG) is scheduled to announce its earnings results for the third quarter of fiscal 2019 before the market opens on April 23.

    By Amit Singh
  • uploads///KMB ANR
    Consumer

    Is Kimberly-Clark Stock Heading for a Decline?

    Kimberly-Clark (KMB) stock has increased 8.1% so far this year and trades at a forward PE multiple of 18.7x

    By Amit Singh
  • uploads///KMB Sales
    Consumer

    Why Kimberly-Clark’s Sales Could Continue to Decline in Q1

    Kimberly-Clark (KMB) has exceeded analysts’ sales estimate in the past two consecutive quarters.

    By Amit Singh
  • uploads///toilet paper _
    Consumer

    Why Analysts Have a Bleak Outlook for Kimberly-Clark’s Q1

    Kimberly-Clark (KMB) is expected to announce its first-quarter results before the markets open on Monday, April 22.

    By Amit Singh
  • uploads///PG Stock
    Company & Industry Overviews

    Where Clorox Stock Could Be Heading

    Clorox stock is trading at a forward PE multiple of 24.1x, which looks unattractive given its projected growth rate of 6.3% for fiscal 2020.

    By Amit Singh
  • uploads///bottles _
    Company & Industry Overviews

    Why JPMorgan Chase Has Downgraded Clorox Stock

    The Clorox Company (CLX) stock fell ~1% on April 8 after JPMorgan Chase downgraded it to an “underweight” from a “neutral.”

    By Amit Singh
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.